Proguanil and atovaquone use is associated with lower colorectal cancer risk : a nationwide cohort study
Background: Individuals with a family history of colorectal cancer (CRC) are at a high risk of developing CRC. Preclinical studies suggest that the anti-malaria drug proguanil and atovaquone might play a role in preventing CRC, but population-based evidence is still lacking. Methods: By accessing a couple of nationwide Swedish registers, we performed a cohort study to explore whether using proguan
